Prezista label
Interaction Color Code
Clinical Bottom Line
Do not coadminister: Potential for increased levels of ranolazine and darunavir
Drug 1
Drug 2
Clinical Effects
Potential for increased risk of ranolazine adverse effects (e.g. prolonged QT, cardiac arrythmias)
Management
Use alternative agents
Import ID
941
